Genomic engineering involves the manipulation of cellular DNA in order to repair or delete a gene’s function. With new and exciting developments in CRISPR (clustered regularly interspaced short palindromic repeats)/Cas systems for genomic engineering, ESI seeks to improve products related to CRISPR/Cas and related systems. ESI also seeks to provide novel and improved systems for genomic engineering. In addition to products, ESI also provides a range of molecular biology services for its customers, including custom DNA constructs and genetically engineered cell lines.

ESI is also committed to improve and provide new therapies for genetic disorders including forms of visual impairment, cancers, neurological and neuromuscular disorders, cardiovascular disease, and respiratory disorders.

ESI sells products for genomic engineering including products for CRISPR/Cas, TALEN (transcriptor activator-like effector nucleases) and other genomic engineering systems. ESI also sells molecular biology services including DNA cloning projects, quantitative PCR, and production of genetically engineered cells.